9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Estimated reading time: < 1 min

Condition: Cervical Cancer

Estimated Enrollment: 40

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Recruiting

Study Results: No Results Available

Outcome Measures: Number of treatment-emergent adverse events (TEAEs),  Cmax of INCAGN02385,  Tmax of INCAGN02385, Cmin of INCAGN02385

Interventions: INCAGN02385,

Phase:

Study Type: Interventional

Study Design: Intervention Model: Single Group Assignment, Masking: None (Open Label), Primary Purpose: Treatment,

Primary Completion Date: September 24, 2020

Completion Date: September 24, 2020

Last  Posted Date: April 12, 2019

Location: The Angeles Clinic and Research Center, Los Angeles, California, United States

Website Link: https://ClinicalTrials.gov/show/NCT03538028

Was this article helpful?
Dislike 0